Research Focus: Met Pathway and Met Inhibiting Anti-Cancer Agents

In this downloadable slideset, Ravi Salgia, MD, explores the role of the Met pathway in oncogenesis and reviews targeted agents in this setting across several tumor types.
Format: Microsoft PowerPoint (.ppt)
File Size: 1.93 MB
Released: October 3, 2012

Acknowledgements

Educational grant provided by:
Genentech BioOncology
Exelixis

Related Content

Downloadable slides from live event at ASCO GI Cancers Symposium 2019 review future directions for pancreatic cancer with DNA damage repair mutations

Tanios Bekaii-Saab Tanios Bekaii-Saab, MD, FACP Released: January 17, 2019

Downloadable slides from live event held at ASCO GI Cancers Symposium 2019 review key data for PARP inhibition in pancreatic cancer

Eileen M. O'Reilly, MD Released: January 17, 2019

Downloadable slides from live event held at ASCO GI Cancers Symposium 2019 review DNA damage repair mutations and PARP inhibition in pancreatic cancer

John L. Marshall, MD
Program Director
Released: January 17, 2019

Dara L. Aisner, MD, PhD, and Eric Q. Konnick, MD, MS, discuss practical guidance for testing for RET alterations and the latest clinical data on selective RET inhibitors.

Dara L. Aisner, MD, PhD Eric Q. Konnick, MD, MS Released: November 16, 2018

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?